Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02204072
Title BI836845 Plus Enzalutamide in Castrate Resistant Prostate Cancer (CRPC)
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult
Covered Countries USA | NLD | GBR | ESP


No variant requirements are available.